IPO Premiums
IPO calendar
SPListed

Sudeep Pharma Limited

Bookbuilding IPO · NSE, BSE

Price band
₹563 - ₹593
Lot size
25 shares
Issue amount
₹895 cr
Total subscription
93.72×
Current price₹1,003.3
Listing price ₹737
Watch live price ↗
Opens
21 Nov 2025
Closes
25 Nov 2025
Allotment
26 Nov 2025
Listing
28 Nov 2025

Offer at a glance

Issue overview

Issue size
1,50,92,749 shares
Face value
₹1 Per Share
Minimum investment
₹14,075
Fresh issue
₹95 cr
Offer for sale
₹800 cr
Registrar
Link Intime India Private Limited
Listing exchange
NSE, BSE
Maximum investment
₹14,825
Issue type
Bookbuilding IPO
Shares before issue
11,13,46,602
Shares after issue
11,29,48,626

Lot sizes

CategoryLotsSharesAmount
Retail125₹14,825
sHNI14350₹2,07,550
bHNI681,700₹10,08,100

Share reservation

Anchor30%
QIB20%
HNI15%
RETAIL35%

Subscription & GMP

Subscription by category

Total subscribed93.72×

Reported 25 Nov 2025

QIB213.08×
NIB116.72×
RETAIL15.65×
HNIs(10L+)134.91×
HNIs(2-10L)80.33×

GMP history

051.510317 Nov: ₹018 Nov: ₹4519 Nov: ₹10320 Nov: ₹10121 Nov: ₹9423 Nov: ₹10224 Nov: ₹6425 Nov: ₹7026 Nov: ₹8427 Nov: ₹94
17 Nov₹9427 Nov

Day-wise demand

21 Nov1.44×
24 Nov5.13×
25 Nov93.72×

Application-wise demand

CategoryReserved applicationsApplied applications
RETAIL2,11,29827,22,863
HNIs(10L +)4,3121,17,655
HNIs (2-10L)2,1561,64,607

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs17938,141.08
FIIs011,221.95
FIs015,279.16
Mutual Funds01,698.7
Others09,941.26
RETAIL313.254,902.41
HNIs 2+44.753,594.84
HNIs 10+89.512,074.65

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profitIn Crores
0200400600Mar-23 · Revenue: 438.26Mar-23 · Profit after tax: 62.32Mar-23Mar-24 · Revenue: 465.38Mar-24 · Profit after tax: 133.15Mar-24Mar-25 · Revenue: 511.33Mar-25 · Profit after tax: 138.69Mar-25Jun-25 · Revenue: 130.08Jun-25 · Profit after tax: 31.27Jun-25
RevenueProfit after tax

Key performance indicators

MetricJun-25Mar-25Mar-24Mar-23
EPS0000
ROE4.5228.1337.4127.91
ROCE5.529.8241.1729.4
RONW0000
PRE IPO(PE)047.6100
POST IPO(PE)53.55000

Values and labels as reported in the issue data.

Company information

Company profile

Sudeep Pharma Limited, incorporated in 1989, is a global manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients, supplying over 200 products to customers in more than 100 countries. The company operates six manufacturing facilities with a total capacity of 50,000 MT, producing key minerals such as calcium, iron, magnesium, zinc, potassium, and sodium. With strong in-house R&D and pilot-scale labs, the company focuses on developing high-quality mineral salts and excipients across its pharmaceutical, food and nutrition, specialty ingredients, and triturates product segments. As of December 31, 2024, it employed 704 permanent staff.

Strengths

  • Strong Market Leadership with a Wide Product Range: A leading manufacturer of pharmaceutical, food, nutrition, and specialty ingredients (as of June 30, 2025), with strong expertise in mineral-based products, iron phosphate, and a broad portfolio of specialty food ingredients such as encapsulated preservatives.
  • Advanced and Fully Compliant Manufacturing Setup: Operates four manufacturing facilities with 12 production lines across Gujarat and Ireland, covering 68,446 sq. meters and offering an annual capacity of 72,246 MT, ensuring efficient production and regulatory compliance.
  • Innovation Driven by Strong R&D Capabilities: Equipped with two R&D centers and a team of 41 specialists focusing on particle engineering, shelf-life enhancement, nutrient bioavailability, and advanced formulation solutions, supported by modern equipment to drive technology improvements, sustainability, and product expansion.

Risk factors

  • High Dependence on Key Customers: A major share of revenue is concentrated among a limited set of customers, making the business vulnerable to reduced orders or the loss of any key client, which could impact financial performance and cash flow.
  • Strict Regulatory and Quality Compliance Requirements: Manufacturing units are regularly inspected and must meet standards prescribed by global agencies such as USFDA, EXCiPACT, FSSC, WHO-GMP, ISO, and HACCP. Any deviation, quality lapse, or non-compliance could lead to regulatory action and harm the company’s reputation.
  • Risk of Operational Disruptions: Manufacturing and R&D activities face potential threats from equipment breakdowns, industrial accidents, regulatory issues, natural calamities, or outbreaks of infectious diseases. Any disruption or shutdown could negatively affect business operations, financial results, and liquidity.

Promoters

Sujit Jaysukh Bhayani

Avani Sujit Bhayani

Shanil Sujit Bhayani

Sujeet Jaysukh Bhayani HUF

Riva Resources Private Limited

Bhayani Family Trust

Registrar & documents

Lead manager

ICICI Securities Limited, IIFL Capital Services Limited

Registered office

129/1/A, GIDC Estate, Nandesari, Vadodara, Gujarat, 391340

+91 265 284 0656

[email protected]Company website ↗

Frequently Asked Questions

What is Sudeep Pharma IPO GMP today?

As of today, Sudeep Pharma IPO Grey Market Premium (GMP) is reported at +₹94 per share. Based on the upper price band of ₹593, the estimated listing price is ₹687 (+15.9% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for Sudeep Pharma IPO?

The minimum bid lot size for Sudeep Pharma IPO is 25 shares. At the cut-off price of ₹593 per share, retail investors need a minimum application amount of ₹14,825 per lot. Retail applicants can apply for a maximum of 13 lots (up to ₹2,00,000).

When will Sudeep Pharma IPO allotment status be announced?

The allotment status for Sudeep Pharma IPO is scheduled to be finalized on 26 Nov 2025. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Link Intime India Private Limited's official portal or via BSE/NSE allotment portals.

How can I check Sudeep Pharma IPO allotment status online by PAN?

To check Sudeep Pharma IPO allotment status: 1) Visit the registrar portal (Link Intime India Private Limited) or the BSE IPO allotment page. 2) Select 'Sudeep Pharma Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.
Sudeep Pharma IPO GMP Today, Subscription Status & Allotment Date | IPO Premiums